Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Sphingolipidosis
ASAH1-related sphingolipidosis
A spectrum of disorders caused by variation(s) in the ASAH1 genel this spectrum includes Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. The ASAH1 gene encodes the lysosomal hydrolase that breaks down the bioactive lipid, ceramide.
-
Farber lipogranulomatosis 1 trial